Ideaya Biosciences Correlations

IDYA Stock

USD 26.99 0.21 0.78%

The current 90-days correlation between Ideaya Biosciences and AnaptysBio is 0.28 (i.e., Modest diversification). The correlation of Ideaya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Ideaya Biosciences Correlation With Market

Very weak diversification

The correlation between Ideaya Biosciences and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Moving together with Ideaya Stock

0.69	ELAN	Elanco Animal Health Potential Growth	Pair Corr
0.73	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.73	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.81	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.78	RDY	Dr Reddys Laboratories	Pair Corr
0.8	TAK	Takeda Pharmaceutical	Pair Corr
0.64	INMB	INmune Bio	Pair Corr
0.71	LTRN	Lantern Pharma	Pair Corr
0.72	REVB	Revelation Biosciences	Pair Corr
0.75	AMGN	Amgen Inc	Pair Corr
0.66	ANRO	Alto Neuroscience,	Pair Corr
0.83	SIGA	SIGA Technologies	Pair Corr

Moving against Ideaya Stock

0.81	EWTX	Edgewise Therapeutics	Pair Corr
0.8	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.77	BHC	Bausch Health Companies	Pair Corr
0.73	GILD	Gilead Sciences	Pair Corr
0.69	ESPR	Esperion Therapeutics	Pair Corr
0.6	GANX	Gain Therapeutics	Pair Corr
0.49	WAT	Waters	Pair Corr
0.41	VTRS	Viatris	Pair Corr
0.41	EBS	Emergent Biosolutions	Pair Corr
0.41	BCTXW	BriaCell Therapeutics	Pair Corr
0.4	BFRIW	Biofrontera Warrants	Pair Corr
0.36	HCM	HUTCHMED DRC	Pair Corr
0.79	BSX	Boston Scientific Corp	Pair Corr
0.44	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.43	DXCM	DexCom Inc	Pair Corr
0.39	ABT	Abbott Laboratories Fiscal Year End 22nd of January 2025	Pair Corr
0.35	MNMD	Mind Medicine	Pair Corr

Related Correlations Analysis

	ANAB	MGTX	KROS	FIXX	VTYX	PTGX	VRNA	SNDX	CERE	RNA
ANAB		-0.78	-0.41	0.55	0.46	0.15	-0.8	0.36	0.09	-0.15	ANAB
MGTX	-0.78		0.58	-0.3	-0.09	0.17	0.91	-0.17	-0.19	0.43	MGTX
KROS	-0.41	0.58		-0.22	0.14	0.53	0.61	0.12	-0.07	0.62	KROS
FIXX	0.55	-0.3	-0.22		0.38	0.11	-0.26	-0.06	-0.22	0.14	FIXX
VTYX	0.46	-0.09	0.14	0.38		0.62	-0.18	0.42	-0.45	0.15	VTYX
PTGX	0.15	0.17	0.53	0.11	0.62		0.16	0.39	-0.09	0.28	PTGX
VRNA	-0.8	0.91	0.61	-0.26	-0.18	0.16		-0.3	-0.26	0.38	VRNA
SNDX	0.36	-0.17	0.12	-0.06	0.42	0.39	-0.3		0.19	0.18	SNDX
CERE	0.09	-0.19	-0.07	-0.22	-0.45	-0.09	-0.26	0.19		0.03	CERE
RNA	-0.15	0.43	0.62	0.14	0.15	0.28	0.38	0.18	0.03		RNA
	ANAB	MGTX	KROS	FIXX	VTYX	PTGX	VRNA	SNDX	CERE	RNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VRNA	+ 0.91	MGTX
RNA	+ 0.62	KROS
PTGX	+ 0.62	VTYX
VRNA	+ 0.61	KROS
KROS	+ 0.58	MGTX
FIXX	+ 0.55	ANAB

High negative correlations

VRNA	- 0.8	ANAB
MGTX	- 0.78	ANAB
CERE	- 0.45	VTYX
KROS	- 0.41	ANAB
SNDX	- 0.3	VRNA
FIXX	- 0.3	MGTX

Risk-Adjusted Indicators

There is a big difference between Ideaya Stock performing well and Ideaya Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ideaya Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANAB	3.46	(0.81)	0.00	(0.14)	0.00	0.00	5.77	(7.28)	35.57
MGTX	2.68	0.56	0.21	0.42	2.48	(3.03)	6.75	(5.68)	21.07
KROS	2.09	0.26	0.12	0.30	2.19	(2.25)	4.39	(4.31)	16.94
FIXX	2.82	0.04	0.01	0.16	3.52	(3.25)	5.77	(5.61)	19.43
VTYX	3.36	0.09	0.08	0.15	3.12	(4.50)	6.96	(5.63)	16.88
PTGX	1.91	(0.07)	0.00	0.07	2.29	(1.92)	3.70	(3.74)	14.61
VRNA	2.20	0.58	0.22	1.76	1.79	(2.56)	7.31	(3.34)	14.37
SNDX	2.31	(0.55)	0.00	(0.11)	0.00	0.00	4.02	(4.33)	34.00
CERE	0.77	0.10	(0.04)	(0.39)	0.94	(1.02)	1.91	(1.59)	6.40
RNA	2.92	(0.14)	(0.01)	0.04	4.23	(2.99)	5.78	(7.08)	27.94

Ideaya Biosciences Corporate Management

Mick OQuigley	Chief Development	Profile
Stu Dorman	Chief Officer	Profile
Paul Stone	CFO VP	Profile
JD Esq	Chief Secretary	Profile
Matthew MD	VP Oncology	Profile
Esq JD	Gen VP	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC